Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Wiskott-Aldrich Syndrome: later-stage trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Wiskott-Aldrich Syndrome: 5 US clinical trials tracked, none currently recruiting.
Wiskott-Aldrich Syndrome is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Bio Products Laboratory, running 1 of these trials.
Enrollment posture brief
Registry condition wiskott-aldrich-syndrome
OPEN 0 | RECR 0% | LATE 2 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Wiskott-Aldrich Syndrome has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Wiskott-Aldrich Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Wiskott-Aldrich Syndrome is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Wiskott-Aldrich Syndrome research.
Bio Products Laboratory accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Wiskott-Aldrich Syndrome trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Wiskott-Aldrich Syndrome research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Masonic Cancer Center, University of Minnesota
NCT01652092
Immune Disorder HSCT Protocol
Washington University School of Medicine
NCT01821781
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
Fondazione Telethon
NCT03837483
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02064933
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
Bio Products Laboratory
NCT00278954
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Wiskott-Aldrich Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Wiskott-Aldrich Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Wiskott-Aldrich Syndrome page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Wiskott-Aldrich Syndrome trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bio Products Laboratory sponsors the most Wiskott-Aldrich Syndrome trials on record, review their full trial history before evaluating a specific study. See Bio Products Laboratory's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Wiskott-Aldrich Syndrome condition card totals 5 registered trials; most-linked intervention Gammaplex (Intravenous immunoglobulin); top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.